SG Morning Call | Brokerages Lift Their STI Targets as Earnings Drive Momentum into Q4
Market Snapshot
Singapore stocks opened lower on Monday. STI fell 0.3%; OCBC and SGX fell 0.7%; DBS fell 0.4%; SIA fell 0.3%.
Stocks in Focus
$CSE Global(544.SI)$: The company on Friday said its appointed financial adviser – Jefferies Singapore – in connection with the strategic review, has submitted a preliminary report which the board of CSE Global is currently reviewing. It added that there is “no certainty or assurance” any definitive agreement will be entered into, or any transaction will materialise from the strategic review. Shares of CSE Global ended 1.7 per cent or S$0.02 higher at S$1.18 prior to the news.
$Marco Polo Marine(5LY.SI)$: On Monday, it entered a conditional sale and purchase agreement with Fuji Offset Plates Manufacturing, in relation to a proposed reverse takeover transaction announced on May 15. The consideration of the proposed takeover is up to S$139 million, and comprises a base consideration of S$120 million and a deferred consideration of up to S$19 million. Shares of Marco Polo Marine ended 0.8 per cent or S$0.001 higher at S$0.129 before the news.
$iX Biopharma(42C.SI)$: The Catalist-listed drug company on Monday said that it is closer to using its sublingual ketamine wafer to treat military casualties after the US officially opened a rare emergency regulatory route for battlefield pain medications. It expects to submit its emergency use application to the Federal Drug Authority in the fourth quarter. This would enable the company to deploy Wafermine to US armed forces ahead of full FDA approval, unlocking commercial revenue early while Phase 3 clinical trials proceed in parallel. The counter rose 2.2 per cent to close S$0.01 higher at S$0.475 on Thursday, before it called for a trading halt on Friday that has since been lifted.
SG Local News
Brokerages Lift Their STI Targets as Earnings Drive Momentum into Q4
With the final quarter of 2026 almost here, some brokerages have raised their targets for Straits Times Index (STI), reflecting a growing optimism underpinned by solid corporate earnings and macroeconomic resilience.
The consensus 12-month target for the STI now stands at 6,140 points, implying about a 5.5 per cent upside, SGX market strategist Geoff Howie wrote in an Aug 27 note.
Thilan Wickramasinghe, head of research at Maybank, outlines a bull-case 12-month target of 6,800 points.
UOB Kay Hian analysts on Aug 25 set a target of 6,682 points, which represents an 18 per cent upside for the STI.
DBS on Monday (Aug 31) introduced a 12-month target of 6,110 points, applying a 5 per cent discount to the aggregated bottom-up target of 6,430 points, while simultaneously raising its year-end target to 5,850 points.
Jayden Vantarakis, head of Asean equity research at Macquarie Group, in July upgraded his 12-month target for the STI to 6,000 points, implying a 14 per cent total market return when factoring in a 4.1 per cent dividend yield.
Temasek, Portfolio Firms Need to Make Commercial Decisions Without Fear of Politicisation: Shanmugam
Temasek portfolio companies must not fear making investment decisions because of political pressure or politically motivated criticism, said Senior Minister and Coordinating Minister for National Security K Shanmugam on Sep 5.
Addressing recent racist comments surrounding Singapore Airlines’ (SIA) investment in Air India, he warned that if corporate boards become overly cautious to avoid politicisation, it will compromise investment returns in the long run and ultimately disadvantage Singaporeans.
The news of Air India seeking US$1.5 billion in fresh equity from its shareholders, after posting a record loss of US$2 billion in the last financial year, sparked a recent wave of racist comments online in Singapore.
$(STI.SI)$ $(544.SI)$ $(5LY.SI)$ $(42C.SI)$ $(ES3.SI)$ $(G3B.SI)$ $(GAB.SI)$Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

